B cells and B-cell/T-cell collaborations are instrumental in the pathophysi
ology of systemic lupus erythematosus (SLE). This commentary highlights in
particular the newly discovered role of B-cell-activating factor (BAFF; als
o known as TALL-1, THANK, BlyS, and zTNF4) as a positive regulator of B-cel
l functions, such as B-cell activation and differentiation. Two members of
the tumor necrosis factor(TNF)-receptor superfamily were recently identifie
d as receptors for BAFF on B cells. The interaction between BAFF and its re
ceptors may be important in the pathogenesis of lupus. Advances in our unde
rstanding of abnormalities in immune regulation in lupus might provide the
opportunity to improve our current therapeutic approaches to this disorder.